Tudor Investment Corp ET AL Has $51,000 Holdings in Community Health Systems, Inc. (NYSE:CYH)

Tudor Investment Corp ET AL lowered its position in Community Health Systems, Inc. (NYSE:CYH - Free Report) by 96.5% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 17,176 shares of the company's stock after selling 468,910 shares during the period. Tudor Investment Corp ET AL's holdings in Community Health Systems were worth $51,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. Tower Research Capital LLC TRC grew its holdings in Community Health Systems by 250.0% in the fourth quarter. Tower Research Capital LLC TRC now owns 9,023 shares of the company's stock worth $27,000 after purchasing an additional 6,445 shares during the period. Two Sigma Securities LLC bought a new stake in Community Health Systems in the 4th quarter valued at about $33,000. Cibc World Markets Corp bought a new position in Community Health Systems in the fourth quarter worth approximately $35,000. Virtu Financial LLC acquired a new stake in Community Health Systems in the fourth quarter valued at approximately $38,000. Finally, Canada Pension Plan Investment Board acquired a new position in shares of Community Health Systems during the fourth quarter worth approximately $54,000. 84.99% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts have commented on CYH shares. StockNews.com upgraded shares of Community Health Systems from a "sell" rating to a "hold" rating in a research note on Thursday, February 20th. Wells Fargo & Company lowered their target price on shares of Community Health Systems from $2.50 to $2.00 and set an "underweight" rating on the stock in a report on Monday, March 10th. Truist Financial cut their price target on Community Health Systems from $4.00 to $3.00 and set a "hold" rating for the company in a research note on Friday, April 11th. UBS Group set a $3.50 price objective on Community Health Systems in a research note on Friday, April 25th. Finally, Guggenheim initiated coverage on Community Health Systems in a research report on Wednesday, April 9th. They issued a "neutral" rating for the company. Two research analysts have rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $3.92.

Community Health Systems Stock Performance

CYH opened at $3.50 on Friday. The firm has a market cap of $491.07 million, a P/E ratio of -0.90 and a beta of 1.99. Community Health Systems, Inc. has a fifty-two week low of $2.24 and a fifty-two week high of $6.29. The firm has a 50-day moving average of $2.70 and a 200 day moving average of $3.21.

Community Health Systems (NYSE:CYH - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The company reported ($0.03) EPS for the quarter, beating the consensus estimate of ($0.10) by $0.07. The firm had revenue of $3.16 billion during the quarter, compared to analysts' expectations of $3.10 billion. Community Health Systems's revenue for the quarter was up .6% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.14) EPS. Equities research analysts predict that Community Health Systems, Inc. will post -0.29 earnings per share for the current fiscal year.

About Community Health Systems

Community Health Systems, Inc owns, leases, and operates general acute care hospitals in the United States. It offers general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric, and rehabilitation services, as well as skilled nursing and home care services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.